Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Objective: The goal of this study was to systematically evaluate the quality of electronic applications (apps) available for chronic kidney disease (CKD) dietary management.

Methods: The review consisted of (1) a systematic search for all mobile CKD diet apps available on the App Store and Google Play Store, (2) an evaluation to determine how well existing apps met criteria for an ideal app, and (3) a systematic literature review of publications found through Google Scholar, Mendeley, and PubMed that reviewed specific CKD diet apps and the broader field.

Results: After applying systematic search criteria, 10 unique apps were identified. Ten of 14 criteria considered necessary in an ideal CKD diet app were applied to the 13 apps. Important criteria such as tailoring recommendations to CKD stage or individual dietary needs, tracking nutrient intake, allowing data to be accessible to clinicians, availability on different app platforms, and including CKD-friendly recipes were not consistently available in the apps. None of the apps used the most contemporary nutrition guidelines on which to base their recommendations. While the literature suggests there is demand for CKD diet apps, common shortcomings of available apps including barriers to usability, inclusion of erroneous information, the requirement of a high e-literacy level, user costs, lack of privacy, security, and interactive features, and the inability of caregivers or family members to use apps to assist in patient care.

Conclusions: The few CKD dietary apps currently on the market for people with CKD have notable limitations in terms of content and software design. Opportunities therefore exist for improving on available CKD diet apps and thereby fulfilling an important unmet need for patients with CKD.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8799771PMC
http://dx.doi.org/10.1053/j.jrn.2021.06.006DOI Listing

Publication Analysis

Top Keywords

ckd diet
20
diet apps
16
apps
13
ckd
10
chronic kidney
8
kidney disease
8
ckd dietary
8
systematic search
8
diet
5
systematic
4

Similar Publications

Background: The effects of dietary niacin on the risk of cardiovascular disease (CVD) and mortality in patients with chronic kidney disease (CKD) remain unclear.

Methods: CKD patients with estimated glomerular filtration rates (eGFRs) 20-59 mL/min/1.73 m or urinary albumin/creatinine ratio ≥30 mg/g were identified in the National Health and Nutrition Examination Survey (NHANES) data from 2003 to 2018.

View Article and Find Full Text PDF

Chronic kidney disease (CKD) is a complicated systemic disease displaying various pathophysiological symptoms including mineral bone disorder (CKD-MBD). Ideally, early intervention for CKD-MBD would be desirable, however, there is not enough evidence regarding treatment of CKD-MBD, especially in its early stages, due to its multifactorial pathophysiology and the difficulty in generating adequate animal models. In this study, we evaluated the efficacy of a tissue nonspecific alkaline phosphatase (TNAP) inhibitor, SBI-425 in a CKD-MBD animal model, produced by a combination of nephrectomy and high inorganic phosphate (P) diet.

View Article and Find Full Text PDF

Background & Aim: Chronic Kidney Disease (CKD) remains a significant global non-communicable disease (NCD) that affects more than 10% of the world's population. Attention is gradually shifting to tertiary prevention of CKD to avoid End-Stage Renal Disease (ESRD) progression. This study reviewed evidence of the use of a Dietary Approach to Stop Hypertension (DASH) and its effect on disease progression among patients living with CKD.

View Article and Find Full Text PDF

Background: Severity of chronic kidney disease (CKD) is associated with the inflammatory response, and that a decrease in glomerular filtration rate correlates positively with the concentrations of inflammatory markers. Moreover, the severity of the inflammatory response is also exacerbated by the dialysis treatment process. It is also emphasized that the introduction of appropriate dietary interventions alleviates inflammation and reduces the concentration of markers.

View Article and Find Full Text PDF

ND-630, an acetyl-CoA carboxylase inhibitor, prevents renal fibrosis in adenine-induced CKD mice.

Naunyn Schmiedebergs Arch Pharmacol

September 2025

Department of Nephrology, Shenzhen Traditional Chinese Medicine Hospital, Guangzhou University of Chinese Medicine, Shenzhen, 518033, Guangdong, China.

To evaluate the protective potential of ND-630, an acetyl-CoA carboxylase (ACC) inhibitor, in preventing renal fibrosis using an adenine-induced chronic kidney disease (CKD) mouse model. Male C57BL/6 mice were divided into four groups: control, CKD, CKD + ND-630 low-dose (4 mg/kg/d), and CKD + ND-630 high-dose (16 mg/kg/d). CKD was induced by feeding 0.

View Article and Find Full Text PDF